On November 18, 2021 Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, reported that the Company’s management will participate in a fireside chat as part of the Piper Sandler 33rd Annual Virtual Healthcare Conference, being held November 29 – December 2, 2021 (Press release, Supernus, NOV 18, 2021, View Source [SID1234595770]). The Company will also host investor meetings on Wednesday, December 1, 2021.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The pre-recorded fireside chat can be accessed beginning at 10:00 a.m. ET on November 22, 2021 by visiting Events & Presentations in the Investors section on the Company’s website at www.supernus.com. An archived replay of this fireside chat will be available for 60 days on the Company’s website after the conference.